DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTE OF MENTAL HEALTH

Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS)

Identifying Cognitive Targets and Establishing Criteria for Test Selection

Bolger Center
April 14^th - 15^th 2003

AGENDA & SLIDES

View slides by clicking on the Topic links below. View transcripts by clicking on the speaker name.

Monday, April 14th - Day 1
Time	Topic	Presenter/Links to Transcripts
8:00 am-9:00 am	Registration and Continental breakfast
9:00 am–9:05 am	Welcome	Ellen Stover, Ph.D. Director, Division of Mental Disorders, Behavioral Behavioral Research and AIDS, NIMH
9:05 am–9:15 am	Welcome and NIMH Priorities	Tom Insel, M.D. Director, NIMH
9:15 am–9:45 am	Rationale for MATRICS	Wayne Fenton, M.D. Deputy Director for Clinical Affairs, Division of Mental Disorders, Behavioral Research and AIDS, NIMH
9:45 am–10:15 am	Overview of MATRICS Activities	Steve Marder, M.D.
10:15 am–10:25 am	Coffee Break
10:25 am–11:15 am	FDA View of MATRICS	Thomas Laughren, M.D.
11:15 am–11:45 am	Overview of RAND Panel Method	Alexander Young, M.D.
11:45 am–12:15 pm	Goals of Meeting and Expert Interview Results	Michael F. Green, Ph.D.
12:15 pm–1:15 pm	Lunch
1:15 pm–1:45 pm	Cognitive Deficits as Core Features of Schizophrenia	James Gold, Ph.D.
1:45 pm–2:35 pm	Identification of Separable Cognitive Factors in Schizophrenia	Keith H. Nuechterlein, Ph.D.
2:35 pm–3:25 pm	Cognition-Functional Outcome Relationships in Schizophrenia	Michael F. Green, Ph.D.
3:25 pm–3:35 pm	Coffee break
3:35 pm-5:30 pm	Psychometrics and Qualities of Cognitive Tests for Clinical Trials: Presentations and Discussion MATRICS: Measurement Issues from the RCT Viewpoints - Helena Chmura Kraemer, Ph.D. Alternate Test Forms Integrating the WAIS-III and WMS-III: A Co-norming Methodology	Helena Kraemer, Ph.D.   Scott Millis, Ph.D. David Tulsky, Ph.D.
5:30 pm	Summary Wrap Up
Tuesday, April 15th - Day 2
8:00 am-9:00 am	Continental breakfast
9:00 am–10:00 am	Assessments of Functional Outcome: Proxy Measures The Measurement of Functioning in the Community for Individuals with Schizophrenia - John Brekke	Thomas Patterson, Ph.D.     John Brekke, Ph.D.
10:00 am–10:45 am	Panel Discussion with FDA	Thomas Laughren, M.D., Robert Levin, M.D.
10:45 am	Summary Wrap Up
11:00 am	Adjourn
11:00 am – 5:00 pm	Joint Meeting: Neurocognition Committee Committees

Attendees are free to depart after the meeting closes at 11:00, or stay and observe the Joint Meeting.

---

Contact matricsassessment@gmail.com for questions or comments about the MATRICS program and see our website - www.matricsinc.org - for details regarding the MATRICS Consensus Cognitive Battery (MCCB).

Contact support@matrics.ucla.edu for questions or comments about with this web site.

TURNS Home Page | UCLA Home Page | Terms of Use | Disability Resources at UCLA